计算溶液所需的质量、体积或浓度。
这是演示店铺,请务下单付款,避免造成你的财物损失。
为了获得访问"阿拉丁铁蛋"实时聊天框的流畅支持体验,建议您使用Chrome浏览器或选择360浏览器极速模式(如何切换极速模式?),感谢您选择我们!
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
C124969-250mg |
250mg |
现货 ![]() |
| |
C124969-1g |
1g |
现货 ![]() |
| |
C124969-5g |
5g |
现货 ![]() |
| |
C124969-25g |
25g |
现货 ![]() |
| |
C124969-100g |
100g |
现货 ![]() |
|
别名 | 5′-脱氧-5-氟-N-[(戊氧基)羰基]胞苷 |
---|---|
英文别名 | Ro-9-1978;5′-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine;5'-Deoxy-5-fluoro-N⁴-[(pentyloxy)carbonyl]cytidine |
规格或纯度 | ≥99% |
英文名称 | Capecitabine |
生化机理 | Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrμg, that is enzymatically converted to 5-fluorouracil in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. The activation of capecitabine follows a pathway with three enzymatic steps and two intermediary metabolites, 5'-deoxy-5-fluorocytidine (5'-DFCR) and 5'-deoxy-5-fluorouridine (5'-DFUR), to form 5-fluorouracil. From Wikipedia.Selective, novel oral fluoropyrimidine carbamate. Prodrug of 5-Fluorouracil . Anticancer agent. Active in vitro and in vivo . |
应用 | An antiproliferative 5-fluorouracil releasing compound |
储存温度 | -20°C储存 |
运输条件 | 超低温冰袋运输 |
备注 | 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。有毒,请参阅SDS以获取更多信息。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
产品介绍 |
Capecitabine是一种治疗肿瘤选择性的氟嘧啶氨基甲酸酯,具有较高的瘤内5-FU水平,且毒性比5-FU低。An antiproliferative 5-fluorouracil releasing compound Capecitabine is a tumor-selective fluoropyrimidine carbamate which achieves higher intratumoral 5-FU level with lower toxicity than 5-FU. |
PubChem SID | 488183411 |
---|---|
IUPAC Name | pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate |
INCHI | InChI=1S/C15H22FN3O6/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23)/t8-,10-,11-,13-/m1/s1 |
InChi Key | GAGWJHPBXLXJQN-UORFTKCHSA-N |
Canonical SMILES | CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O |
WGK Germany | 3 |
关联CAS | 154361-50-9 |
PubChem CID | 60953 |
MeSH Entry Terms | capecitabine;N(4)-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine;Xeloda |
分子量 | 359.35 |
DrugBank Ligand | DB01101 |
---|---|
PubChem CID | 60953 |
CAS Registry No. | 154361-50-9 |
ChEMBL Ligand | CHEMBL1773 |
Wikipedia | Capecitabine |
ChEBI | CHEBI:31348 |
DrugCentral Ligand | 480 |
PubChem SID | 488183411 |
溶解性 | Soluble in water (26 mg/ml), ethanol (207 mg/ml), methanol (> 40%), DMF (~14 mg/ml), and DMSO (72 mg/ml at 25 °C). |
---|---|
敏感性 | 对热敏感 |
比旋光度 | 98° (C=1,MeOH) |
熔点 | 123 °C(dec.) |
象形图 |
![]() Health Hazard ![]() Harmful |
---|---|
信号词 | Danger |
危险声明 |
H315: Causes skin irritation H319: Causes serious eye irritation H341: Suspected of causing genetic defects H360: May damage fertility or the unborn child H350: May cause cancer |
预防措施声明 | P305+P351+P338,P280,P302+P352,P321,P405,P501,P264,P281,P362+P364,P203,P264+P265,P318,P337+P317,P332+P317 |
WGK Germany | 3 |
Merck Index | 1754 |
输入批号以搜索COA:
1. Shi H et al.. (2014) Anti-angiogenesis participates in antitumor effects of metronomic capecitabine on colon cancer.. Cancer Lett, 349 (2): (128-35). [PMID:24746899] |
2. Miwa M et al.. (1998) Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue.. Eur J Cancer, 34 (8): (1274-81). [PMID:9849491] |
3. Terranova-Barberio M et al.. (2015) Valproic acid potentiates the anticancer activity of capecitabine in vitro and in vivo in breast cancer models via induction of thymidine phosphorylase expression.. Oncotarget, (): (). [PMID:26735339] |